EVALUATION OF INTRAVENOUS LIDOCAINE FOR THE TERMINATION OF SUSTAINED MONOMORPHIC VENTRICULAR-TACHYCARDIA IN PATIENTS WITH CORONARY-ARTERY DISEASE WITH OR WITHOUT HEALED MYOCARDIAL-INFARCTION

被引:41
作者
NASIR, N [1 ]
TAYLOR, A [1 ]
DOYLE, TK [1 ]
PACIFICO, A [1 ]
机构
[1] METHODIST HOSP, CARDIAC ELECTROPHYSIOL UNIT, HOUSTON, TX 77030 USA
关键词
D O I
10.1016/0002-9149(94)90544-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prospective evaluations of intravenous lidocaine as therapy for sustained monomorphic ventricular tachycardia (VT) in the absence of acute myocardial infarction are lacking. Lidocaine has been promulgated as first-line therapy in patients with VT, but studies evaluating its efficacy in the electrophysiology laboratory suggest that it has poor effects in terminating or preventing induction of VT. Thus, this study sought to evaluate the clinical effectiveness of lidocaine in 3 cohorts with induced or spontaneous VT. One hundred twenty-eight patients with stable VT, occurring either spontaneously or induced at the time of electrophysiologic study either in the baseline state or at the time of pharmacologic testing, were evaluated, The response rate to lidocaine therapy as manifested by termination of VT was the primary goal of the study. Of these patients, 10 (8%) had termination of VI after lidocaine therapy. There were no significant differences in age, ejection fraction, VT cycle length, and mean dose of lidocaine between responders and 118 nonresponders; There were no serious side effects or adverse events (death, myocardial infarction, angina, or congestive heart failure). Lidocaine, although safe, is ineffective in terminating stable VT not associated with acute myocardial infarction.
引用
收藏
页码:1183 / 1186
页数:4
相关论文
共 29 条
[11]   RE-ENTRANT VENTRICULAR ARRHYTHMIAS IN LATE MYOCARDIAL-INFARCTION PERIOD .4. MECHANISM OF ACTION OF LIDOCAINE [J].
ELSHERIF, N ;
SCHERLAG, BJ ;
LAZZARA, R ;
HOPE, RR .
CIRCULATION, 1977, 56 (03) :395-402
[12]   MEXILETINE THERAPY IN 15 PATIENTS WITH DRUG-RESISTANT VENTRICULAR-TACHYCARDIA [J].
HEGER, JJ ;
NATTEL, S ;
RINKENBERGER, RL ;
ZIPES, DP .
AMERICAN JOURNAL OF CARDIOLOGY, 1980, 45 (03) :627-632
[13]   META-ANALYTIC EVIDENCE AGAINST PROPHYLACTIC USE OF LIDOCAINE IN ACUTE MYOCARDIAL-INFARCTION [J].
HINE, LK ;
LAIRD, N ;
HEWITT, P ;
CHALMERS, TC .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (12) :2694-2698
[14]   RECURRENT SUSTAINED VENTRICULAR TACHYCARDIA .3. ROLE OF ELECTROPHYSIOLOGIC STUDY IN SELECTION OF ANTIARRHYTHMIC REGIMENS [J].
HOROWITZ, LN ;
JOSEPHSON, ME ;
FARSHIDI, A ;
SPIELMAN, SR ;
MICHELSON, EL ;
GREENSPAN, AM .
CIRCULATION, 1978, 58 (06) :986-997
[15]  
JEWITT DE, 1968, LANCET, V1, P266
[16]   INTRAMUSCULAR LIDOCAINE FOR PREVENTION OF LETHAL ARRHYTHMIAS IN THE PREHOSPITALIZATION PHASE OF ACUTE MYOCARDIAL-INFARCTION [J].
KOSTER, RW ;
DUNNING, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (18) :1105-1110
[17]   LIDOCAINE IN PREVENTION OF PRIMARY VENTRICULAR-FIBRILLATION - DOUBLE-BLIND, RANDOMIZED STUDY OF 212 CONSECUTIVE PATIENTS [J].
LIE, KI ;
WELLENS, HJ ;
VANCAPEL.FJ ;
DURRER, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (25) :1324-1326
[18]   EFFECTS OF PROPHYLACTIC LIDOCAINE IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - AN OVERVIEW OF RESULTS FROM THE RANDOMIZED, CONTROLLED TRIALS [J].
MACMAHON, S ;
COLLINS, R ;
PETO, R ;
KOSTER, RW ;
YUSUF, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (13) :1910-1916
[19]   EFFECTS OF CLASS-I DRUGS ON REENTRANT VENTRICULAR-TACHYCARDIA IN A CANINE MODEL OF MYOCARDIAL-INFARCTION - ON THEIR ANTIARRHYTHMIC AND PROARRHYTHMIC MECHANISMS [J].
MIYAZAKI, T ;
OGAWA, S ;
SAKAI, T ;
HOSOKAWA, M ;
SAKURAI, K ;
NAKAMURA, Y .
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1988, 52 (03) :254-261
[20]   PH-DEPENDENT ELECTRO-PHYSIOLOGICAL EFFECTS OF QUINIDINE AND LIDOCAINE ON CANINE CARDIAC PURKINJE-FIBERS [J].
NATTEL, S ;
ELHARRAR, V ;
ZIPES, DP ;
BAILEY, JC .
CIRCULATION RESEARCH, 1981, 48 (01) :55-61